< Back to previous page
Researcher
Zhigang Wang
- Disciplines:Gastro-enterology, Biopharmaceuticals, Clinical pharmacy, Pharmacotherapy
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Mar 2022 → Today - Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Mar 2020 → 26 Apr 2022
Projects
1 - 1 of 1
- A Pharmacometrics Approach to Improve Dose Individualisation Methods of Biologicals in Patients with Chronic Inflammatory DiseasesFrom13 Oct 2020 → TodayFunding: FWO fellowships
Publications
1 - 4 of 4
- Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases(2022)
Authors: Wannee Kantasiripitak, Zhigang Wang, Isabel Spriet, Marc Ferrante, Erwin Dreesen
Pages: 1455 - 1466Number of pages: 12 - Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis(2021)
Authors: Ruben Faelens, Zhigang Wang, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Number of pages: 11 - Population pharmacokinetic-pharmacodynamic model-based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease(2021)
Authors: Zhigang Wang, Bram Verstockt, João Pedro Guedelha Sabino, Séverine Vermeire, Marc Ferrante, Paul Declerck, Erwin Dreesen
Pages: 323 - 335Number of pages: 13 - Therapeutic drug monitoring of anti-tumor necrosis factor agents: lessons learned and remaining issues(2020)
Authors: Zhigang Wang, Erwin Dreesen
Pages: 53 - 59Number of pages: 7